StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
566
This year
181
Publishing Date
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 09 - 27
2
2021 - 09 - 21
2
2021 - 09 - 17
2
2021 - 09 - 15
2
2021 - 08 - 31
2
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 26
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Sector
Commercial services
5
Communications
1
Consumer durables
1
Consumer non-durables
2
Consumer services
1
Distribution services
1
Electronic technology
4
Energy minerals
1
Finance
14
Finance and insurance
3
Health care and social assistance
1
Health services
3
Health technology
566
Manufacturing
25
N/a
7
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
4
Retail trade
1
Technology services
3
Tags
Acquire
4
Acquisition
5
Application
6
Approval
6
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
5
Collaboration
8
Conference
19
Device
5
Diabetes
31
Disease
15
Drug
17
Earnings
8
Europe
10
Events
21
Expansion
7
Expected
10
Fda
10
Financial
7
Financial results
7
Genetown
7
Global
42
Growing
5
Growth
29
Hormone
7
Insulin
29
Iot
6
License
5
Liver
11
Market
70
Money
6
N/a
457
Obesity
14
People
11
Pharma
79
Pharmaceutical
12
Phase 1
5
Phase 2
7
Phase 3
6
Program
10
Reach
7
Report
34
Repurchase
77
Research
31
Results
19
S
42
Sales
12
Sanofi
6
Space
5
Study
5
Technology
10
Therapeutics
20
Therapy
11
Treatment
29
Trial
29
Trials
8
Update
8
Entities
89bio, inc.
2
Abbott laboratories
19
Abbvie inc.
12
Alexion pharmaceuticals, inc.
23
Alnylam pharmaceuticals, inc.
25
Altimmune, inc.
2
Amgen inc.
15
Astellas pharma inc
2
Astrazeneca plc
26
Bausch health companies inc.
2
Baxter international inc.
8
Becton, dickinson and company
12
Biodelivery sciences international, inc.
2
Biogen inc.
6
Blackrock, inc.
5
Bnp paribas
3
Boston scientific corporation
3
Bristol-myers squibb company
5
Charles river laboratories international, inc.
2
Csl ltd
3
Denali therapeutics inc.
2
Dexcom, inc.
3
Dicerna pharmaceuticals, inc.
27
Eiger biopharmaceuticals, inc.
2
Eli lilly and company
77
Endo international plc
5
Entera bio ltd.
2
Forma therapeutics holdings, inc.
3
Galectin therapeutics inc.
3
Genmab a/s
4
Gilead sciences, inc.
8
Glaukos corporation
2
Glaxosmithkline plc
26
Global blood therapeutics, inc.
2
Icon plc
5
Incannex healthcare ltd
2
Innate pharma s.a.
70
Innate pharma sa
43
Insulet corporation
11
Ionis pharmaceuticals, inc.
2
Johnson & johnson
39
Kamada ltd.
2
Karyopharm therapeutics inc.
2
Lipocine inc.
3
Madrigal pharmaceuticals, inc.
3
Mallinckrodt plc
2
Mannkind corporation
2
Medtronic plc
14
Mylan n.v.
6
Novartis ag
25
Novo nordisk a/s
566
Pfizer, inc.
10
Retractable technologies, inc.
4
Sanofi
132
Takeda pharmaceutical company limited
14
Terumo corp
9
Teva pharmaceutical industries ltd
14
Thermo fisher scientific inc
4
Viatris inc.
6
Zealand pharma a/s
9
Symbols
AAPL
1091
ABB
1301
ABBV
908
ABLZF
1041
ABT
1543
AMGN
694
ARVL
3798
AZN
587
BDX
722
BMY
597
BNPQF
1628
BNPQY
1628
BNPZY
1627
CNY
2011
CSCO
808
DHR
724
ERIC
1459
EXTR
581
FNCTF
6070
GE
851
GLAXF
604
GOOG
1094
GOOGL
1094
GSK
824
HON
1612
HUBS
1290
IBM
604
INR
2014
INTC
874
JNJ
3972
LLY
1546
LTUM
869
LYV
717
MDT
1192
MLPY
2012
MMM
868
MS
3637
MS-PE
1440
MSFT
1126
NOK
824
NOKBF
884
NVO
566
NVS
1108
NVSEF
901
ORCL
1080
PCRFF
590
PCRFY
590
PFE
642
PHG
884
PPRUF
1004
PPRUY
1005
SAP
1397
SAPGF
1131
SNOW
705
SNY
3985
SNYNF
3040
TMO
1427
TOT
1591
URR
2010
VZ
1056
Exchanges
Amex
5
Lse
10
Nasdaq
246
Nyse
566
Crawled Date
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 09 - 13
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 23
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 10 - 03
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 09 - 15
2
2021 - 08 - 31
2
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 27
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Crawled Time
00:00
5
00:20
3
01:00
7
02:00
6
03:00
1
04:00
3
04:20
5
05:00
5
06:00
32
07:00
31
07:04
1
08:00
24
09:00
14
10:00
27
11:00
29
11:33
1
12:00
59
12:15
9
12:20
16
12:30
6
13:00
34
13:15
7
13:20
9
13:30
5
14:00
34
14:05
1
14:15
3
14:20
6
14:30
2
15:00
36
15:01
1
15:15
2
15:20
8
15:30
6
16:00
22
16:20
2
17:00
19
17:01
1
18:00
16
19:00
12
20:00
14
20:20
1
21:00
19
21:06
1
22:00
14
23:00
7
Source
www.aspenpharma.com
1
www.biospace.com
106
www.globenewswire.com
303
www.prnewswire.com
156
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvo
save search
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Published:
2023-11-28
(Crawled : 12:30)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
-2.91%
|
O:
-2.88%
H:
0.37%
C:
-0.43%
PDSB
|
$5.25
-0.19%
0.0%
550K
|
Health Technology
|
-14.05%
|
O:
-6.86%
H:
0.7%
C:
-6.49%
PODD
|
$192.19
1.64%
-3.32%
930K
|
Health Technology
|
1.42%
|
O:
-0.18%
H:
1.19%
C:
-0.21%
biotech
financial
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-27
(Crawled : 14:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
-2.4%
|
O:
0.53%
H:
0.0%
C:
0.0%
repurchase
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Published:
2023-11-23
(Crawled : 16:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
Email alert
Add to watchlist
expansion
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-20
(Crawled : 15:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
Email alert
Add to watchlist
repurchase
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published:
2023-11-15
(Crawled : 22:00)
- prnewswire.com
LLY
2 d
|
$584.04
-1.18%
0.34%
3.6M
|
Health Technology
|
-2.7%
|
O:
-3.12%
H:
0.61%
C:
-0.46%
VRTX
|
$351.16
-1.03%
0.7%
1.1M
|
Health Technology
|
-4.05%
|
O:
-5.15%
H:
0.38%
C:
-2.2%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
2.56%
|
O:
1.54%
H:
0.0%
C:
0.0%
companies
diabetes
study
market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-14
(Crawled : 11:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
2.42%
|
O:
0.32%
H:
0.0%
C:
0.0%
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-13
(Crawled : 20:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
2.42%
|
O:
0.32%
H:
0.0%
C:
0.0%
repurchase
Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-13
(Crawled : 12:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
1.64%
|
O:
-0.77%
H:
0.0%
C:
0.0%
Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine
Published:
2023-11-11
(Crawled : 16:20)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
Email alert
Add to watchlist
wegovy
association
sessions
heart
cardiovascular
Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published:
2023-11-11
(Crawled : 04:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
LLY
2 d
|
$584.04
-1.18%
0.34%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
report
astrazeneca
global
market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-10
(Crawled : 12:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
1.06%
|
O:
-0.57%
H:
0.0%
C:
0.0%
Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark
Published:
2023-11-10
(Crawled : 07:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
1.06%
|
O:
-0.57%
H:
0.0%
C:
0.0%
expansion
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-07
(Crawled : 15:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
0.75%
|
O:
-0.32%
H:
1.23%
C:
0.92%
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programme
Published:
2023-11-06
(Crawled : 21:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
0.75%
|
O:
-0.32%
H:
1.23%
C:
0.92%
repurchase
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-06
(Crawled : 21:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
0.75%
|
O:
-0.32%
H:
1.23%
C:
0.92%
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-06
(Crawled : 13:30)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
3.49%
|
O:
1.44%
H:
1.67%
C:
1.25%
Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Published:
2023-11-03
(Crawled : 17:00)
- prnewswire.com
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
10.98%
|
O:
2.32%
H:
0.0%
C:
0.0%
QGEN
|
$41.45
0.71%
0.92%
880K
|
Health Technology
|
7.67%
|
O:
2.29%
H:
0.0%
C:
0.0%
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
0.9%
|
O:
-2.5%
H:
0.0%
C:
0.0%
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
4.69%
|
O:
-0.57%
H:
0.0%
C:
0.0%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
5.99%
|
O:
2.15%
H:
0.0%
C:
0.0%
BDX
S
|
$238.25
0.88%
0.37%
1.5M
|
Health Technology
|
-7.89%
|
O:
0.76%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.04%
|
O:
-3.04%
H:
0.0%
C:
0.0%
QGEN
|
$41.45
0.71%
0.92%
880K
|
Health Technology
|
7.78%
|
O:
2.29%
H:
0.0%
C:
0.0%
global
hiv
diagnostics
therapeutics
market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-03
(Crawled : 14:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
0.9%
|
O:
-2.5%
H:
0.0%
C:
0.0%
Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
Published:
2023-11-02
(Crawled : 07:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
4.62%
|
O:
4.05%
H:
0.96%
C:
-0.35%
sales
Novo Nordisk A/S - share repurchase programme
Published:
2023-11-01
(Crawled : 17:00)
- globenewswire.com
NVO
|
$100.4
-1.41%
0.3%
4.6M
|
Health Technology
|
5.59%
|
O:
0.92%
H:
0.0%
C:
0.0%
repurchase
← Previous
1
2
3
4
5
6
7
8
9
…
28
29
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
BKKT
4
|
$1.88
25.33%
14.89%
4.8M
|
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
SATX
|
$0.4226
-1.72%
6.48%
29K
|
n/a
CCJ
|
$45.4
-1.13%
4.6%
3.9M
|
Non-Energy Minerals
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
JBL
|
$116.91
1.38%
4.3%
2M
|
Electronic Technology
SAIC
4
|
$119.92
2.14%
4.24%
460K
|
Technology Services
CULP
4
|
$5.06
-0.59%
3.95%
29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.